CARsgen Therapeutics Holdings Ltd

Lobbying Transparency and Governance

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Direct Lobbying Transparency
Overall Assessment Comment Score
None No evidence found 0
Lobbying Governance
Overall Assessment Comment Score
None The evidence provided focuses exclusively on financial oversight without reference to lobbying governance. It states that “The Audit Committee currently comprises two independent non-executive Directors, namely, Mr. Tak Young SO and Dr. Huabing LI, and one non-executive Director, namely Mr. Huaqing GUO,” and that the committee “has reviewed the audited Consolidated Financial Statements for the year ended December 31, 2022 with the management and the auditor of the Company” and “discussed matters with respect to the accounting policies and practices adopted by the Company and internal control with senior management of the Company.” We found no evidence of any internal mechanisms, oversight structures, or processes for governing direct or indirect lobbying activities, nor any reference to alignment of lobbying with climate or other policy goals. 0